UPDATE: BioNTech (BNTX) PT Lowered to $255 at Goldman Sachs
Tweet Send to a Friend
(Updated - March 31, 2022 10:57 AM EDT)
Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
